GE Sells BioPharma Business to Danaher for $21.4 Billion, an Industrial Info Market Brief

---

The Danaher Corporation is paying $21.4 billion for GE's BioPharma business. A solid moneymaker, BioPharma generates more than $3 billion in annual sales for GE. The company's increasingly popular KUBio prefabricated biomanufacturing facilities are being shipped across the world.

After the deal closes in late 2019, the business will operate under Danaher's Life Science Group, joining Pall Corporation, Beckman Coulter, SCIEX, Leica Microsystems, Molecular Devices, Phenomenex and Integrated DNA Technologies.

Industrial Info is monitoring construction of the $165 million KUBio park in Ringaskiddy, Cork, Ireland.